Milk Proteins and Micronutrient Supplementation in Obese Children

March 23, 2020 updated by: Jorge Luis Rosado Loria, Universidad Autónoma de Querétaro

Effectiveness of a Supplement Containning Milk Proteins, Vitamins and Minerals to Reduce Fat Deposition, Systemic Inflammation and Improve Nutritional Status in Obese School-age Children

Milk proteins and micronutrients could be beneficial in the prevention and treatment of obesity.

The objective was to evaluate a supplement with milk proteins and multivitamins and minerals with nutrition education on anthropometry, body composition, micronutrient status, blood pressure, lipid profile, systemic inflammation, leptin and insulin resistance in obese children at baseline and after 6 months.

Study Overview

Detailed Description

Obese children were selected in elementary schools from 5 rural communities of the State of Querétaro. One hundred fifty two obese children (Z-score >2 standard deviations) aged 6-11y were randomly assigned to receive one of two treatments: 1) 237mL/day of milk proteins and multiple micronutrients supplement (MPMS) plus Nutrition Education (NE) program or 2) NE alone for 24 weeks.

Children in both groups were evaluated at baseline and 6 months after treatment initiated. At both times the following variables were evaluated:

Visit 1 (Screening): Mothers and parents received oral and written information regarding all aspects of the study. Informed consent, medical history, demographic information, weight and height were obtained.

Visit 2 (Clinical Laboratory testing): A blood preasure and sample was taken by an specialist. Blood test included Glucose, total cholesterol, triglycerides, HDL cholesterol and LDL cholesterol, Tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10), C reactive protein, insulin and leptin.

Visit 3 (Nutrition Clinic at UAQ): body composition was determined by DEXA. The NE were given at Nutrition Clinic and school to the children's parents each week.

Study Type

Interventional

Enrollment (Actual)

152

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 11 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children with obesity (BMI>30)
  • Aged: 6 to 11 years
  • Both sex
  • Parents accepted to participate and signed informant consent

Exclusion Criteria:

  • Children with dyslipidemia
  • Metabolic disease
  • Hypertension
  • Physical disability
  • Using vitamins and minerals supplements and/or receiving treatment for obesity during the last 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supplement with micronutrients
Nutrition education with a supplement
Obese children were divided in 2 groups. A group received the supplement plus nutrition education and other group was a control, only received nutrition education.
Experimental: Nutrition education
Group received only nutrition education
Group received nutrition education program during 6 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total body fat
Time Frame: baseline to 6 months
change in fat
baseline to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total cholesterol
Time Frame: Beaseline to 6 months
Change in total cholesterol
Beaseline to 6 months
HDL
Time Frame: Baseline to 6 months
change in HDL
Baseline to 6 months
LDL
Time Frame: baseline to 6 months
change in LDL
baseline to 6 months
Triglycerides
Time Frame: baseline to 6 months
change in triglycerides
baseline to 6 months
Glucose
Time Frame: baseline to 6 months
change in glucose
baseline to 6 months
Interleukin 6 (IL-6)
Time Frame: baseline to 6 months
Change in IL-6
baseline to 6 months
Interleukin 10 (IL-10)
Time Frame: baseline to 6 months
change of IL-10 change in IL-10
baseline to 6 months
C reactive protein (CRP)
Time Frame: baseline to 6 months
change of CRP
baseline to 6 months
Bone mineral density (BMD)
Time Frame: baseline to 6 months
change in BMD
baseline to 6 months
Body mass index (BMI)
Time Frame: Baseline to 6 months
Change in BMI
Baseline to 6 months
Zinc levels
Time Frame: baseline to 6 months
Change in zinc levels
baseline to 6 months
Iron levels
Time Frame: baseline to 6 months
Change in iron levels
baseline to 6 months
A vitamin levels
Time Frame: baseline to 6 months
change in A vitamin levels
baseline to 6 months
C vitamin levels
Time Frame: baseline to 6 months
change of C vitamin levels
baseline to 6 months
D vitamin levels
Time Frame: baseline to 6 months
change in D vitamin levels
baseline to 6 months
E vitamin levels
Time Frame: baseline to 6 months
change of E vitamin levels
baseline to 6 months
Systolic blood pressure (SBP)
Time Frame: baseline to 6 months
change in SBP
baseline to 6 months
Diastolic blood pressure (DBP)
Time Frame: baseline to 6 months
change in (DBP)
baseline to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2011

Primary Completion (Actual)

December 5, 2012

Study Completion (Actual)

December 5, 2012

Study Registration Dates

First Submitted

February 28, 2020

First Submitted That Met QC Criteria

March 23, 2020

First Posted (Actual)

March 24, 2020

Study Record Updates

Last Update Posted (Actual)

March 24, 2020

Last Update Submitted That Met QC Criteria

March 23, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Childhood

Clinical Trials on Supplement with micronutrients

3
Subscribe